ETFsXtrackers II EUR Corporate Bond Short Duration SRI PAB UCITS ETF 1C
Xtrackers

Xtrackers II EUR Corporate Bond Short Duration SRI PAB UCITS ETF 1C

XZE5 XETRAAccumulatingLuxembourg
Last close · EUR
47.71EUR
+0.04% · +€0.02
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XZE5Base
Fund charges
Not publishedFee basis unverified
Fund size
Not published
Return 1Y
+0.3%
Sharpe 3Y
0.32
Volatility 1Y
1.9%annualised
Holdings
2,181Fund holdings

Performance

Compare
  • XZE5+0.3%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
XZE5+0.5%-0.1%+0.3%+0.4%+0.3%+11.3%+6.0%
MSCI World+0.4%+4.9%+10.8%+16.0%+15.9%+75.5%+71.2%
Gap to MSCI World0.0%-5.0%-10.5%-15.6%-15.5%-64.2%-65.2%

Risk and return

Sharpe ratio · 3Y
0.32
Below MSCI World · 1.24
Return p.a.
+3.4%
Volatility
1.8%
Max loss
-1.7%Mar 2026

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
XZE5
0.32
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
2.4%
Holdings
2,181
As of
Fund holdings
  1. 1DEUTSCHE GLOBAL LIQUIDITY SERIIE00BZ3FDF201.11%
  2. 2AMAZON.COM INCXS33051687940.17%
  3. 3VERIZON COMMUNICATIONS INCXS32265428610.16%
  4. 4NOVARTIS FINANCE SAXS22359962170.16%
  5. 5SANOFI SAFR00133243570.15%
  6. 6MICROSOFT CORPORATIONXS10017492890.14%
  7. 7THERMO FISHER SCIENTIFIC (FINAN)XS23664070180.13%
  8. 8ALPHABET INCXS33633864600.13%
  9. 9DH EUROPE FINANCE II SARLXS20504060940.13%
  10. 10AT&T INCXS21800075490.12%

Countries

Classified 99.9%
Largest
21.4%United States
Top 3
50.8%
Effective number
9.01 / HHI

Market cap

Weight vs holdings

2.4%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.